Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
America Movil
AMX
$61.7B
| $7.64M | ﹤0.01% |
467,108
+182,009
| +64% | +$2.98M |
|
|
BCAX
1602
Bicara Therapeutics Inc. Common Stock
BCAX
$621M
| $7.63M | ﹤0.01% |
+299,559
| New | +$7.63M |
|
|
ESGR
1603
DELISTED
Enstar Group
ESGR
| $7.63M | ﹤0.01% |
23,715
-17,030
| -42% | -$5.48M |
|
1604
Rubrik
RBRK
$14.9B
| $7.62M | ﹤0.01% |
237,060
+32,481
| +16% | +$1.04M |
|
1605
Harrow
HROW
$1.58B
| $7.6M | ﹤0.01% |
168,933
+30,796
| +22% | +$1.38M |
|
1606
Enanta Pharmaceuticals
ENTA
$159M
| $7.58M | ﹤0.01% |
731,295
+48,152
| +7% | +$499K |
|
|
AAT
1607
American Assets Trust
AAT
$1.26B
| $7.57M | ﹤0.01% |
283,144
+173,668
| +159% | +$4.64M |
|
1608
BrightView Holdings
BV
$1.29B
| $7.56M | ﹤0.01% |
480,601
-151,970
| -24% | -$2.39M |
|
1609
Fresh Del Monte Produce
FDP
$1.7B
| $7.56M | ﹤0.01% |
256,018
-380,405
| -60% | -$11.2M |
|
1610
Elbit Systems
ESLT
$23.3B
| $7.55M | ﹤0.01% |
37,754
+8,550
| +29% | +$1.71M |
|
1611
iShares US Medical Devices ETF
IHI
$4.21B
| $7.55M | ﹤0.01% |
+127,437
| New | +$7.55M |
|
1612
Intel
INTC
$116B
| $7.53M | ﹤0.01% |
320,988
-494,497
| -61% | -$11.6M |
|
|
BDN
1613
Brandywine Realty Trust
BDN
$796M
| $7.52M | ﹤0.01% |
1,383,146
+1,124,492
| +435% | +$6.12M |
|
1614
Designer Brands
DBI
$218M
| $7.52M | ﹤0.01% |
1,018,520
+2,728
| +0.3% | +$20.1K |
|
1615
Leonardo DRS
DRS
$11.2B
| $7.51M | ﹤0.01% |
266,122
+172,215
| +183% | +$4.86M |
|
1616
Relay Therapeutics
RLAY
$700M
| $7.5M | ﹤0.01% |
1,059,607
-89,570
| -8% | -$634K |
|
1617
MarineMax
HZO
$562M
| $7.5M | ﹤0.01% |
212,558
-189,420
| -47% | -$6.68M |
|
1618
Symbotic
SYM
$5.72B
| $7.5M | ﹤0.01% |
307,356
-28,293
| -8% | -$690K |
|
1619
Movado Group
MOV
$442M
| $7.48M | ﹤0.01% |
402,116
+321,831
| +401% | +$5.99M |
|
1620
Paymentus
PAY
$4.03B
| $7.48M | ﹤0.01% |
373,565
+87,784
| +31% | +$1.76M |
|
|
ABVX
1621
Abivax
ABVX
$6.49B
| $7.44M | ﹤0.01% |
645,637
+568,035
| +732% | +$6.54M |
|
1622
Loews
L
$20.1B
| $7.42M | ﹤0.01% |
93,875
-7,212
| -7% | -$570K |
|
1623
Duke Energy
DUK
$95.2B
| $7.42M | ﹤0.01% |
64,351
+4,535
| +8% | +$523K |
|
1624
Edgewell Personal Care
EPC
$984M
| $7.42M | ﹤0.01% |
204,103
+194,317
| +1,986% | +$7.06M |
|
1625
Archrock
AROC
$4.24B
| $7.41M | ﹤0.01% |
366,186
-1,977,466
| -84% | -$40M |
|